• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增生异常综合征的预后因素:138例患者的多变量分析

Prognostic factors in myelodysplasic syndromes: a multivariante analysis in 138 patients.

作者信息

Avilés A, Ovilla R, García L D, Rubio M E, González-Llaven J

出版信息

Arch Invest Med (Mex). 1989 Jan-Mar;20(1):45-52.

PMID:2764668
Abstract

A multivariate analysis of clinical, biochemical and hematologic data was performed in 138 patients with myelodysplastic syndromes (MDS) in order to evaluate their prognostic significance. The most important individual variables, isolated in a previous univariate analysis, were placed in a multiple regression modeling procedure to identify major prognostic factors. Multivariate analysis tends to identify prognostic variables containing significant predictive information. Characteristics were examined on both continuous and binary bases. The FAB classification was the first parameter entered in regression equations of both models, followed by platelet count, systemic symptoms, bone marrow blast and infection. Our analysis confirms FAB classification as the best prognostic factor in MDS. It supports the previously predictive value of platelet count, hemoglobin level and bone marrow blast and recognizes the importance of systemic symptoms and infection as prognostic characteristics in MDS.

摘要

对138例骨髓增生异常综合征(MDS)患者的临床、生化和血液学数据进行了多变量分析,以评估其预后意义。在先前的单变量分析中分离出的最重要的个体变量,被纳入多元回归建模程序,以识别主要的预后因素。多变量分析倾向于识别包含显著预测信息的预后变量。对连续和二元特征均进行了检查。FAB分类是两个模型回归方程中输入的第一个参数,其次是血小板计数、全身症状、骨髓原始细胞和感染。我们的分析证实FAB分类是MDS中最佳的预后因素。它支持血小板计数、血红蛋白水平和骨髓原始细胞先前的预测价值,并认识到全身症状和感染作为MDS预后特征的重要性。

相似文献

1
Prognostic factors in myelodysplasic syndromes: a multivariante analysis in 138 patients.骨髓增生异常综合征的预后因素:138例患者的多变量分析
Arch Invest Med (Mex). 1989 Jan-Mar;20(1):45-52.
2
Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases.慢性骨髓增生异常综合征的预后因素:107例病例的多变量分析
Am J Hematol. 1988 Mar;27(3):163-8. doi: 10.1002/ajh.2830270303.
3
International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.国际骨髓增生异常综合征风险分析研讨会(IMRAW)/国际预后评分系统(IPSS)重新分析:血细胞减少对骨髓增生异常综合征临床结局的影响
Am J Hematol. 2008 Oct;83(10):765-70. doi: 10.1002/ajh.21249.
4
Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.影响巴西人群骨髓增生异常综合征生存的因素:FAB与WHO分类的比较
Leuk Res. 2004 Jun;28(6):587-94. doi: 10.1016/j.leukres.2003.11.001.
5
Detection of risk groups in myelodysplastic syndromes. A multicenter study.骨髓增生异常综合征风险组的检测。一项多中心研究。
Haematologica. 2002 Jan;87(1):9-16.
6
Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.骨髓增生异常综合征中血管生成与临床分期、细胞凋亡及预后评分的关系
Leuk Res. 2006 Mar;30(3):247-53. doi: 10.1016/j.leukres.2005.07.003. Epub 2005 Aug 15.
7
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution.骨髓增生异常综合征:单一机构143例患者中八种预后系统的预测价值
Haematologica. 1999 Jan;84(1):12-6.
8
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.循环髓系集落形成细胞可预测骨髓增生异常综合征的生存率。
Ann Hematol. 2003 May;82(5):271-7. doi: 10.1007/s00277-003-0619-z. Epub 2003 Mar 22.
9
Myelodysplastic syndromes: a community hospital-based study of prognostic factors and International Prognostic Scoring System.骨髓增生异常综合征:一项基于社区医院的预后因素及国际预后评分系统研究
Conn Med. 2001 Aug;65(8):455-63.
10
Evaluating the prognosis of patients with myelodysplastic syndromes.评估骨髓增生异常综合征患者的预后。
Ann Hematol. 2002 Sep;81(9):485-97. doi: 10.1007/s00277-002-0530-z. Epub 2002 Sep 24.